» Articles » PMID: 21892298

The 'Pokemon' (ZBTB7) Gene: No Evidence of Association with Sporadic Breast Cancer

Overview
Journal Clin Med Oncol
Publisher Libertas Academica
Specialty Oncology
Date 2011 Sep 6
PMID 21892298
Authors
Affiliations
Soon will be listed here.
Abstract

It has been proposed that the excess of familiar risk associated with breast cancer could be explained by the cumulative effect of multiple weakly predisposing alleles. The transcriptional repressor FBI1, also known as Pokemon, has recently been identified as a critical factor in oncogenesis. This protein is encoded by the ZBTB7 gene. Here we aimed to determine whether polymorphisms in ZBTB7 are associated with breast cancer risk in a sample of cases and controls collected in hospitals from North and Central Spanish patients. We genotyped 15 SNPs in ZBTB7, including the flanking regions, with an average coverage of 1 SNP/2.4 Kb, in 360 sporadic breast cancer cases and 402 controls. Comparison of allele, genotype and haplotype frequencies between cases and controls did not reveal associations using Pearson's chi-square test and a permutation procedure to correct for multiple test. In this, the first study of the ZBTB7 gene in relation to, sporadic breast cancer, we found no evidence of an association.

References
1.
Maeda T, Hobbs R, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C . Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature. 2005; 433(7023):278-85. DOI: 10.1038/nature03203. View

2.
Wedren S, Lovmar L, Humphreys K, Magnusson C, Melhus H, Syvanen A . Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study. Breast Cancer Res. 2004; 6(4):R437-49. PMC: 468663. DOI: 10.1186/bcr811. View

3.
Berstein J, Concannon P, Langholz B, Thompson W, Bernstein L, Stovall M . Multi-center screening of mutations in the ATM gene among women with breast cancer - the WECARE Study. Radiat Res. 2005; 163(6):698-9. View

4.
. A haplotype map of the human genome. Nature. 2005; 437(7063):1299-320. PMC: 1880871. DOI: 10.1038/nature04226. View

5.
Milne R, Ribas G, Gonzalez-Neira A, Fagerholm R, Salas A, Gonzalez E . ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping. Cancer Res. 2006; 66(19):9420-7. DOI: 10.1158/0008-5472.CAN-06-1418. View